Russell Investments Group Ltd. grew its holdings in shares of Phibro Animal Health Corp (NASDAQ:PAHC) by 7.6% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 44,173 shares of the company’s stock after acquiring an additional 3,105 shares during the period. Russell Investments Group Ltd. owned about 0.11% of Phibro Animal Health worth $1,636,000 as of its most recent SEC filing.

Several other institutional investors have also made changes to their positions in PAHC. Aperio Group LLC grew its stake in shares of Phibro Animal Health by 5.8% during the second quarter. Aperio Group LLC now owns 10,098 shares of the company’s stock valued at $374,000 after acquiring an additional 551 shares in the last quarter. Municipal Employees Retirement System of Michigan grew its stake in shares of Phibro Animal Health by 3.6% during the second quarter. Municipal Employees Retirement System of Michigan now owns 4,370 shares of the company’s stock valued at $162,000 after acquiring an additional 150 shares in the last quarter. Schwab Charles Investment Management Inc. grew its stake in shares of Phibro Animal Health by 1.9% during the second quarter. Schwab Charles Investment Management Inc. now owns 144,235 shares of the company’s stock valued at $5,344,000 after acquiring an additional 2,721 shares in the last quarter. Arizona State Retirement System grew its stake in shares of Phibro Animal Health by 1.0% during the second quarter. Arizona State Retirement System now owns 9,800 shares of the company’s stock valued at $363,000 after acquiring an additional 100 shares in the last quarter. Finally, Rhumbline Advisers grew its stake in Phibro Animal Health by 4.1% in the second quarter. Rhumbline Advisers now owns 36,185 shares of the company’s stock worth $1,341,000 after purchasing an additional 1,418 shares in the last quarter. Institutional investors own 48.42% of the company’s stock.

Phibro Animal Health Corp (NASDAQ:PAHC) opened at $34.20 on Tuesday. The company has a market capitalization of $1,340.00, a PE ratio of 20.12, a P/E/G ratio of 4.12 and a beta of 1.27. Phibro Animal Health Corp has a 52 week low of $26.10 and a 52 week high of $40.25. The company has a quick ratio of 1.85, a current ratio of 3.26 and a debt-to-equity ratio of 1.91.

Phibro Animal Health (NASDAQ:PAHC) last posted its quarterly earnings results on Monday, November 6th. The company reported $0.38 EPS for the quarter, topping the Zacks’ consensus estimate of $0.37 by $0.01. Phibro Animal Health had a return on equity of 42.75% and a net margin of 8.87%. The business had revenue of $193.40 million during the quarter, compared to the consensus estimate of $189.89 million. During the same period last year, the firm earned $0.36 earnings per share. The company’s revenue for the quarter was up 2.9% compared to the same quarter last year. analysts anticipate that Phibro Animal Health Corp will post 1.57 EPS for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, December 27th. Shareholders of record on Wednesday, December 6th will be issued a $0.10 dividend. The ex-dividend date of this dividend is Tuesday, December 5th. This represents a $0.40 dividend on an annualized basis and a yield of 1.17%. Phibro Animal Health’s dividend payout ratio is currently 23.53%.

A number of equities analysts recently commented on the company. Piper Jaffray Companies set a $41.00 price target on Phibro Animal Health and gave the stock a “buy” rating in a research note on Friday, October 6th. Zacks Investment Research downgraded Phibro Animal Health from a “buy” rating to a “hold” rating in a research note on Wednesday, November 1st. BidaskClub upgraded Phibro Animal Health from a “strong sell” rating to a “sell” rating in a research note on Thursday, December 21st. Credit Suisse Group lifted their price target on Phibro Animal Health from $36.00 to $37.00 and gave the stock an “outperform” rating in a research note on Thursday, August 31st. Finally, ValuEngine downgraded Phibro Animal Health from a “buy” rating to a “hold” rating in a research note on Thursday, November 9th. Three analysts have rated the stock with a sell rating, one has assigned a hold rating and two have given a buy rating to the stock. Phibro Animal Health has an average rating of “Hold” and a consensus target price of $38.25.

ILLEGAL ACTIVITY WARNING: This news story was reported by TheOlympiaReport and is the property of of TheOlympiaReport. If you are reading this news story on another publication, it was illegally stolen and reposted in violation of United States and international copyright law. The legal version of this news story can be read at https://theolympiareport.com/2017/12/26/phibro-animal-health-corp-pahc-stake-increased-by-russell-investments-group-ltd.html.

About Phibro Animal Health

Phibro Animal Health Corporation (Phibro) is a global diversified animal health and mineral nutrition company. The Company operates in three segments, which include Animal Health, Mineral Nutrition and Performance Products. The Company offers various products, which include Animal health products, such as antibacterials, anticoccidials, vaccines, nutritional specialty products and mineral nutrition products.

Want to see what other hedge funds are holding PAHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Phibro Animal Health Corp (NASDAQ:PAHC).

Institutional Ownership by Quarter for Phibro Animal Health (NASDAQ:PAHC)

Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.